JV
Insider
Jeff L Vacirca
DirectorJeff L Vacirca (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Caris Life Sciences, Inc. (CAI). Across 1 priced purchase filing, the average 21-session return was +4.8% from execution and +5.5% from disclosure (delay-adjusted; derived). The largest single filing was $501K of CAI (31,050 sh × $16.15, as filed), executed May 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+4.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+5.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$501K
shares × price, as filed
Last traded
May 11
Filed May 12
Median ADV $49.4M across their filed names
Open performance→Volume by month
Buys $501K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CAIRecent filings
CAIPURCHASE
Caris Life Sciences, Inc.
View filing →
$501K31,050 sh × $16.15
Exec May 11
Filed May 12 · 8:22 AM ET